Arthur F Golden bought $59k of TTRX
director at Turn Therapeutics Inc.. 20,532 shares at an average of $2.87, traded Nov 21, 2025, filed Nov 24, 2025.
Score components
- +15RoleDirector
- +7Trade size$59k at market
- +10Relative to holdingsHoldings up 68%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -15.1%, 3m -1.7%, 6m +46.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-25-113841, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2025 | POpen-market purchase Common Stock | +20,532 | $2.87 | $59k | 50,734 | Nov 24, 2025 |
Related signals
Other insiders at Turn Therapeutics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 26Weak | TTRXbuy Turn Therapeutics Inc. | Zuraiz Chaudhary See Remarks | $8,750 2,500 shares | +25% | |
| 37Weak | Turn Therapeutics Inc. | Arthur F Golden director | $34k 9,868 shares | +19% | |
| 34Weak | Turn Therapeutics Inc. | Zuraiz Chaudhary See Remarks | $7,075 2,450 shares | +32% | |
| 34Weak | Turn Therapeutics Inc. | Zuraiz Chaudhary See Remarks | $9,050 2,500 shares | +50% | |
| 26Weak | Turn Therapeutics Inc. | Abraham Chesed other | $66k 14,286 shares | +1% | |
| 38Weak | Turn Therapeutics Inc. | Zuraiz Chaudhary See Remarks | $25k 5,050 shares | - | |
| 50Moderate | Turn Therapeutics Inc. | Arthur F Golden director | $100k 20,202 shares | +202% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.